Back to search

Article

Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention

2026-03-29

Abstract excerpt

Thrombosis remains a major cause of cardiovascular and cerebrovascular diseases, driven in large part by platelet activation and aggregation. Because platelets are continuously produced from hematopoietic stem cells (HSCs), durable reprogramming of HSC output offers a unique opportunity for a one-time antithrombotic intervention. Here, we show that DNA methylation-based epigenome editors delivered transiently as R...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
314dd4de-dd13-57a7-8a4d-7fd66f8c3e70
DOI
10.64898/2026.03.27.714536
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis preventionDOI 10.64898/2026.03.27.714536
Select a neighboring publication to make it the new centre.